FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308257879> ?p ?o ?g. }

• W4308257879 endingPage "441" @default.
• W4308257879 startingPage "433" @default.
• W4308257879 abstract "Panoramic views of post-marketing safety profiles, such as cancer signal, of phosphodiesterase 5A (PDE5A) inhibitors have yet to be fully evaluated.Data from the FDA Adverse Event Reporting System (FAERS) concerning the timeframe between January 1st, 2004 to 30 June 2022 was analyzed through a disproportionality study to understand the association between sildenafil, tadalafil, and vardenafil and cancer. This association was identified using the Reporting odds ratio (ROR) and Bayesian Confidence Propagation Neural Network (BCPNN) approaches.Sildenafil associated ROR values and IC025 ranged from 9.19 (95% CI 7.72-10.94, IC025 2.77) for metastatic malignant melanoma to 132.23 (95% CI 95.49-183.11, IC025 4.69) for malignant melanoma stage II. Tadalafil associated ROR and IC025 ranged from 6.79 (95% CI 5.41-8.54, IC025 2.27) for metastatic malignant melanoma to 180.17 (95% CI 130.11-249.50, IC025 4.89) for malignant melanoma stage II. Vardenafil associated ROR and IC025 ranged from 23.38 (95% CI 15.20-35.96, IC025 2.63) for metastatic malignant melanoma to 245.77 (95% CI 154.42-391.16, IC025 2.10) for malignant melanoma stage III.This study supports the association between sildenafil, tadalafil, and vardenafil with skin cancer signal in erectile dysfunction (ED) patients." @default.
• W4308257879 created "2022-11-09" @default.
• W4308257879 creator A5030660225 @default.
• W4308257879 creator A5034544317 @default.
• W4308257879 creator A5052441498 @default.
• W4308257879 creator A5054703064 @default.
• W4308257879 creator A5056437949 @default.
• W4308257879 creator A5063058741 @default.
• W4308257879 creator A5081946864 @default.
• W4308257879 date "2022-11-11" @default.
• W4308257879 modified "2023-09-23" @default.
• W4308257879 title "Skin cancer signal associated with phosphodiesterase inhibitors: gaining insight through the FDA pharmacovigilance database" @default.
• W4308257879 cites W1772001174 @default.
• W4308257879 cites W1864178760 @default.
• W4308257879 cites W1898135975 @default.
• W4308257879 cites W1915143997 @default.
• W4308257879 cites W1934602670 @default.
• W4308257879 cites W1967695112 @default.
• W4308257879 cites W1972891674 @default.
• W4308257879 cites W1978090329 @default.
• W4308257879 cites W1991468702 @default.
• W4308257879 cites W1996239270 @default.
• W4308257879 cites W1996548604 @default.
• W4308257879 cites W2000101702 @default.
• W4308257879 cites W2010544163 @default.
• W4308257879 cites W2015487160 @default.
• W4308257879 cites W2029124536 @default.
• W4308257879 cites W2110210123 @default.
• W4308257879 cites W2133104620 @default.
• W4308257879 cites W2143539434 @default.
• W4308257879 cites W2167089172 @default.
• W4308257879 cites W2192257199 @default.
• W4308257879 cites W2293355601 @default.
• W4308257879 cites W2330422482 @default.
• W4308257879 cites W2362741058 @default.
• W4308257879 cites W2442855507 @default.
• W4308257879 cites W2514799635 @default.
• W4308257879 cites W2615193500 @default.
• W4308257879 cites W2786977496 @default.
• W4308257879 cites W2911375005 @default.
• W4308257879 cites W2914601166 @default.
• W4308257879 cites W2974968593 @default.
• W4308257879 cites W3006676570 @default.
• W4308257879 cites W3047562657 @default.
• W4308257879 cites W3161319147 @default.
• W4308257879 cites W4211128726 @default.
• W4308257879 cites W4220757798 @default.
• W4308257879 doi "https://doi.org/10.1080/14740338.2023.2145280" @default.
• W4308257879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36334066" @default.
• W4308257879 hasPublicationYear "2022" @default.
• W4308257879 type Work @default.
• W4308257879 citedByCount "1" @default.
• W4308257879 countsByYear W43082578792023 @default.
• W4308257879 crossrefType "journal-article" @default.
• W4308257879 hasAuthorship W4308257879A5030660225 @default.
• W4308257879 hasAuthorship W4308257879A5034544317 @default.
• W4308257879 hasAuthorship W4308257879A5052441498 @default.
• W4308257879 hasAuthorship W4308257879A5054703064 @default.
• W4308257879 hasAuthorship W4308257879A5056437949 @default.
• W4308257879 hasAuthorship W4308257879A5063058741 @default.
• W4308257879 hasAuthorship W4308257879A5081946864 @default.
• W4308257879 hasConcept C121608353 @default.
• W4308257879 hasConcept C126322002 @default.
• W4308257879 hasConcept C143998085 @default.
• W4308257879 hasConcept C156957248 @default.
• W4308257879 hasConcept C16005928 @default.
• W4308257879 hasConcept C197934379 @default.
• W4308257879 hasConcept C2776768464 @default.
• W4308257879 hasConcept C2777658100 @default.
• W4308257879 hasConcept C2778822586 @default.
• W4308257879 hasConcept C2780816001 @default.
• W4308257879 hasConcept C44249647 @default.
• W4308257879 hasConcept C502942594 @default.
• W4308257879 hasConcept C57658597 @default.
• W4308257879 hasConcept C71924100 @default.
• W4308257879 hasConcept C74534348 @default.
• W4308257879 hasConcept C98274493 @default.
• W4308257879 hasConceptScore W4308257879C121608353 @default.
• W4308257879 hasConceptScore W4308257879C126322002 @default.
• W4308257879 hasConceptScore W4308257879C143998085 @default.
• W4308257879 hasConceptScore W4308257879C156957248 @default.
• W4308257879 hasConceptScore W4308257879C16005928 @default.
• W4308257879 hasConceptScore W4308257879C197934379 @default.
• W4308257879 hasConceptScore W4308257879C2776768464 @default.
• W4308257879 hasConceptScore W4308257879C2777658100 @default.
• W4308257879 hasConceptScore W4308257879C2778822586 @default.
• W4308257879 hasConceptScore W4308257879C2780816001 @default.
• W4308257879 hasConceptScore W4308257879C44249647 @default.
• W4308257879 hasConceptScore W4308257879C502942594 @default.
• W4308257879 hasConceptScore W4308257879C57658597 @default.
• W4308257879 hasConceptScore W4308257879C71924100 @default.
• W4308257879 hasConceptScore W4308257879C74534348 @default.
• W4308257879 hasConceptScore W4308257879C98274493 @default.
• W4308257879 hasIssue "5" @default.
• W4308257879 hasLocation W43082578791 @default.
• W4308257879 hasLocation W43082578792 @default.
• W4308257879 hasOpenAccess W4308257879 @default.
• W4308257879 hasPrimaryLocation W43082578791 @default.

• next